Compare Illinois Tool Works Inc. (ITW) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illinois Tool Works Inc. vs Zoetis Inc — how do they compare? Illinois Tool Works Inc. trades at $293.28 (market cap $83.49B), while Zoetis Inc trades at $73.7 (market cap $31.14B). The key difference: Illinois Tool Works Inc. is far larger — about 2.7× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| ITW | ZTS | |
|---|---|---|
Market Cap | $83.49B | $31.14B |
Sector | Industrials | Health |
52-Week High | $299.60 | $156.76 |
52-Week Low | $241.07 | $71.91 |
Enterprise Value | $92.34B | $38.70B |
Dividend Yield | 2.35% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ITW trades at $292.54, down 0.67% on the day, with a bullish technical signal and strong fundamentals including a 19.39% net income margin and consistent earnings beats. Recent news highlights a 7% dividend increase and a $6 billion share repurchase program, reflecting management confidence. The stock is near key support at $290 with resistance at $300.
Outlook is positive due to robust profitability and shareholder returns, but risks include high valuation multiples and debt levels. Analyst consensus is mixed with a $314.25 price target, suggesting moderate upside potential amid cautious sentiment from some institutional sellers.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
